Skip to content

News

Press Release: Ovarian Cancer Advocates Praise Supreme Cour...

Press Release: Ovarian Cancer Advocates Praise Supreme Court Decision on Gene Patents

Ruling Will Give Women More Options to Learn About Genetic Risk Washington, DC—The Supreme Court ruled today that a company cannot patent naturally occurring genes, including isolated gene segments, overturning a decision made by the United States Court of Appeals for the Federal Circuit in August 2012, which upheld a patent claim on the BRCA1 … Continued

New Meta-Analysis of Oral Contraception and Risk of Ovarian...

New Meta-Analysis of Oral Contraception and Risk of Ovarian Cancer

A new meta-analysis of more than 6000 studies shows that oral contraceptives significantly reduce the risk of ovarian cancer. The risk reduction increases proportionally with duration of use. See the abstract here

Experts Tackle Key Issues for Ovarian Cancer in New White P...

Experts Tackle Key Issues for Ovarian Cancer in New White Paper

Last fall, the Alliance convened a ground-breaking meeting in Washington, DC, to consider some of the most challenging topics facing the ovarian cancer community. A group of researchers, oncologists, regulatory experts, advocates and industry representatives attempted to answer questions such as: “How can more women be treated where they live?” “How can we facilitate increased … Continued

Report from the American Association of Cancer Researchers ...

Report from the American Association of Cancer Researchers Meeting

Ovarian cancer survivor Susan Leighton reports on her experience at the American Association of Cancer Researchers meeting, which took place in April 2013. For the second year in a row I had the privilege of being selected to attend the Scientist-Survivor Program (SSP) of the American Association of Cancer Researchers. The SSP program was established … Continued

Report from the Society of Gynecologic Oncology 2013 Annual...

Report from the Society of Gynecologic Oncology 2013 Annual Meeting

At this year’s Society of Gynecologic Oncology (SGO) Annual Meeting, numerous presentations and posters explored issues related to ovarian cancer, some of which are summarized below. This year’s SGO Annual Meeting theme, “Embrace the Past, Revolutionize the Future,” was especially fitting given the changing landscape of ovarian cancer treatment. As the Cancer Genome Atlas reveals … Continued

Our CEO Calaneet Balas Testifies Before Congress on Ovarian...

Our CEO Calaneet Balas Testifies Before Congress on Ovarian Cancer

Calaneet Balas, OCNA’s Chief Executive Officer, testified before the House Subcommittee on Labor, Health and Human Services, Education, and Related Agencies on Wednesday, March 13. Her remarks touched on the importance of federal funding for ovarian cancer education and research through the National Cancer Institute and Centers for Disease Control and Prevention. Summing up our … Continued

Press Release: Cancer Groups Praise Coverage of Genetic Cou...

Press Release: Cancer Groups Praise Coverage of Genetic Counseling and Testing Under Affordable Care Act, Urge Coverage of Other Vital Services

For immediate release: February 28, 2013 Washington, DC—The federal government recently released regulations that clarify which preventive services will be covered under the Affordable Care Act without cost sharing for patients enrolled in private insurance plans. Preventive services are provided without cost sharing to people enrolled in private plans that were established after August 1, … Continued

Expanding Medicaid Could Help Women with Ovarian Cancer

Expanding Medicaid Could Help Women with Ovarian Cancer

Many people who live near the poverty line are surprised to learn that they do not qualify for health insurance under Medicaid. Each state sets its own rules for this program, based on income and other qualifying factors. This may soon change, thanks to a provision in the health reform law that encourages states to … Continued

Supreme Court to Hear Gene Patent Case

Supreme Court to Hear Gene Patent Case

The Supreme Court of the United States will hear arguments in a case seeking to invalidate the patents on the BRCA1 and BRCA2 mutations. The patent-holder, Myriad Laboratories, owns patents on the genetic mutations themselves. The Alliance has joined the suit, led by the ACLU. Read the ACLU’s press release here

HHS Releases Health Reform Rules

HHS Releases Health Reform Rules

On Tuesday, the Department of Health and Human Services released three regulations related to implementation of health reform. One of these rules concerned guaranteed issue and a ban on pre-existing condition exclusion for adults. To learn more about these regulations see the article here The 131 pages of regulations can be found here

NIH to Enforce Public Access Policy

NIH to Enforce Public Access Policy

As a condition of receiving public monies for research, the researchers must make available the results of their work. The National Institutes of Health will begin to delay grants to those who do not comply with this policy. When a bill was introduced to cripple this policy, the Alliance worked with the patient advocacy community … Continued

An Open Letter to President Obama from the Ovarian Cancer N...

An Open Letter to President Obama from the Ovarian Cancer National Alliance

This morning the Ovarian Cancer National Alliance sent a letter to President Obama congratulating him on his re-election and outlining some of our policy priorities for his second term. Click here to view a pdf of the letter, or read it below. November 7, 2012 President Barack Obama 1600 Pennsylvania Avenue, NW Washington, DC 20500 … Continued

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

We care about your data. Read our privacy policy.